Akari Therapeutics PLC logo

Akari Therapeutics PLC - ADR

FRA:CLA (USA)   ADR
€ 2.82 (+10.16%) Jun 21
At Loss
Market Cap:
€ 33.11M ($ 35.40M)
Enterprise V:
€ 31.89M ($ 34.09M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Akari Therapeutics PLC Valuation Measures